Efficacy and Safety of Neoadjuvant Immunotherapy plus Chemotherapy versus Neoadjuvant Chemotherapy in Non‐Small Cell Lung Cancer Treatment: A Mixed Method Meta‐Analysis Based on Global Randomized Controlled Trials

MedComm (2020) · 2025 · PMC12126597

Europe PMC

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Among them, the combination of ipilimumab and nivolumab showed notable clinical significance (RR 0.46 [0.16, 1.27]), though it did not reach statistical significance, potentially due to the sparse network connections.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.